AGP Ltd. (AGP) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Healthy long term growth as Net Sales has grown by an annual rate of 32.60%

The company has declared Positive results for the last 3 consecutive quarters

With ROE of 24.9, it has a attractive valuation with a 3.6 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

PKR 52,102 Million (Large Cap)

P/E

15.00

Industry P/E

Dividend Yield

1.13%

Debt Equity

0.69

Return on Equity

29.80%

Price to Book

3.66

Revenue and Profits:

Net Sales:

7,160 Million

(Quarterly Results - Mar 2025)

Net Profit:

1,057 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-1.89%

6 Months

7.35%

1 Year

104.49%

2 Years

268.2%

3 Years

118.04%

4 Years

82.41%

5 Years

66.0%

AGP Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

32.92%

EBIT Growth (5y)

30.22%

EBIT to Interest (avg)

7.47

Debt to EBITDA (avg)

1.07

Net Debt to Equity (avg)

0.67

Sales to Capital Employed (avg)

0.95

Tax Ratio

34.87%

Dividend Payout Ratio

41.95%

Pledged Shares

Institutional Holding

ROCE (avg)

24.53%

ROE (avg)

18.74%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.07

EV to EBIT

8.25

EV to EBITDA

7.86

EV to Capital Employed

2.77

EV to Sales

2.53

PEG Ratio

0.16

Dividend Yield

1.05%

ROCE (Latest)

33.63%

ROE (Latest)

27.59%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Bullish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bullish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2025 is 20.93% vs 51.86% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2025 is 126.25% vs 18.07% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7,159.60",
          "val2": "5,920.40",
          "chgp": "20.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,285.10",
          "val2": "1,539.80",
          "chgp": "48.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "385.30",
          "val2": "730.00",
          "chgp": "-47.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,056.80",
          "val2": "467.10",
          "chgp": "126.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "304.80%",
          "val2": "245.50%",
          "chgp": "5.93%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 33.56% vs 29.63% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 62.39% vs 6.94% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "25,033.60",
          "val2": "18,743.10",
          "chgp": "33.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7,305.90",
          "val2": "4,652.60",
          "chgp": "57.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2,693.10",
          "val2": "1,629.10",
          "chgp": "65.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,960.60",
          "val2": "1,823.10",
          "chgp": "62.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "291.80%",
          "val2": "231.20%",
          "chgp": "6.06%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY

Mar'25

Mar'24

Change(%)

Net Sales

7,159.60

5,920.40

20.93%

Operating Profit (PBDIT) excl Other Income

2,285.10

1,539.80

48.40%

Interest

385.30

730.00

-47.22%

Exceptional Items

0.00

Consolidate Net Profit

1,056.80

467.10

126.25%

Operating Profit Margin (Excl OI)

304.80%

245.50%

5.93%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2025 is 20.93% vs 51.86% in Mar 2024

Consolidated Net Profit

YoY Growth in quarter ended Mar 2025 is 126.25% vs 18.07% in Mar 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

25,033.60

18,743.10

33.56%

Operating Profit (PBDIT) excl Other Income

7,305.90

4,652.60

57.03%

Interest

2,693.10

1,629.10

65.31%

Exceptional Items

0.00

Consolidate Net Profit

2,960.60

1,823.10

62.39%

Operating Profit Margin (Excl OI)

291.80%

231.20%

6.06%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 33.56% vs 29.63% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 62.39% vs 6.94% in Dec 2023

All Annual Results

Company CV

About AGP Ltd.

AGP Ltd.

Pharmaceuticals & Biotechnology

AGP Limited is a Pakistan-based pharmaceutical company that manufactures, markets and distributes pharmaceutical and healthcare products. The Company provides products in the areas of anti-infective, antihistamines, antidepressants, anti fibrinolytic, antiobesity, bile therapy and cholagogue, iron preparation, narcotic analgesic, proton pump inhibitor, vitamin B12, anti-inflammatory enzyme, anti-diarrheal, antidiabetic, anti haemorrhoidal, antispasmodics, calcium preparation, medical food supplement, non-narcotic analgesic, tonic, vitamin D plain, anti allergics, antibiotics, antidiarrheal supplement, antimalarial, antiviral, expectorant, muscle relaxant and venotropic agent. The Company sells products under various brands, including Ceclor, Rigix, Osnate, Anafortan, MyHep, Keflex, Chymoral Forte, Splasler P, Urso and Rubifer.

Company Coordinates

Company Details

B-23, S.I.T.E , Karachi None : 75700

Tel: 92 21 111247247

http://agp.com.pk/

Registrar Details